Sensex, Nifty updates on 24 March 2025. The benchmark BSE Sensex jumped 1.4% to 77,984.38, while the NSE Nifty gained 1.32% ...

Kurt Gustafson; Chief Financial Officer, Executive Vice President - Finance; OmniAb Inc. Matthew Foehr; President, Chief Executive Officer, Director; OmniAb Inc. Joe ...

Q4 2024 Earnings Conference Call March 18, 2025 4:30 PM ETCompany ParticipantsKurt Gustafson - Chief Financial OfficerMatt ...

As the industry advances, pharmaceutical companies must address a critical challenge: how to meet this growing demand while managing the escalating costs and complexities associated with ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Actinium Pharmaceuticals (ATNM – Research ...

Pharma companies operate in a highly regulated - and risk-averse - environment. Internally, their operations are likely to be hierarchical, process-led, and (often) slow. So, it’s to be expected ...

Mumbai-based Kilitch Drugs Ltd plans to enter biosimilars and oral solids, including diabetic and weight-loss tablets, and is ...

Eric Karas, Chief Commercial Officer, outlined the company's multi-pronged strategy to increase neffy adoption, focusing on education, payer coverage, and patient awareness. He noted that neffy ...

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03 ...

Ionis Pharmaceuticals, Inc. engages in the development ... and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K.